Lightbridge Q3 net loss widens to $8.3 million from $4.1 million
Lightbridge reported third-quarter 2026 results with no revenue in either period. The net loss widened to $8.3 million, or $(0.23) per share, from $4.1 million, or $(0.16) per share, a year earlier, as research and development and general and administrative spending rose. The company also said it was selected for a DOE program at Idaho National Laboratory, but the filing states that authorization to build and operate the Pilot Factory remains subject to further agreements and reviews.
Key points
- Q3 2026 R&D expenses were $5.3 million, up from $2.0 million; G&A expenses were $5.0 million, up from $3.2 million.
- Nine-month net loss was $20.4 million, or $(0.62) per share, compared with $12.4 million, or $(0.55) per share, in the prior-year period.
- Cash and cash equivalents totaled $236.7 million at September 30, 2026, versus $201.9 million at December 31, 2025.
- About $91.4 million of common stock remained available under the company's $150 million at-the-market program as of September 30, 2026.
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 02, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.